Toggle Main Menu Toggle Search

Open Access padlockePrints

Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patients

Lookup NU author(s): Gemma Vidal Pedrola, Najib NaamaneORCiD, Dr Arthur Pratt, Emeritus Professor Andrew MellorORCiD, Professor John IsaacsORCiD, Dr Amy AndersonORCiD



This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


© 2022 The Authors. Immunology published by John Wiley & Sons Ltd.Age-associated B cells (ABCs) are an immune cell subset linked to autoimmunity, infection and ageing, and whose pathophysiological importance was recently highlighted using single cell synovial tissue profiling. To elucidate their pathophysiological relevance, peripheral blood (PB) ABCs from early rheumatoid arthritis (eRA) patients naïve to disease-modifying anti-rheumatic drugs (DMARDs) were compared with their synovial fluid (SF) counterparts, and to PB ABCs from psoriatic arthritis patients and healthy controls. PB and SF B-cell subsets were phenotyped by multi-parameter flow cytometry, sorted and subjected to gene expression profiling (NanoString nCounter® Immunology V2 Panel) and functional characterization (stimulated cytokine measurements by immunoassay). PB ABCs of eRA patients, which are transcriptionally distinct from those of control cohorts, express chemokine receptors and adhesion molecules, such as CXCR3, that favour homing to inflammatory sites over lymphoid tissue. These cells are an activated, class-switched B-cell subset expressing high levels of HLA-DR, co-stimulatory molecules and T-bet. Their secretion profile includes IL-12p70 and IL-23 but low levels of IL-10. High surface expression of FcRL family members, including FcRL3, furthermore suggests a role for these cells in autoimmunity. Finally, and unlike in the periphery where they are rare, ABCs are the predominant B-cell subsets in SF. These observations indicate the predilection of ABCs for inflammatory tissue in RA, where their propensity for antigen presentation and pro-inflammatory phenotype may support autoimmune pathology. Their potential as a therapeutic target therefore warrants further study.

Publication metadata

Author(s): Vidal-Pedrola G, Naamane N, Cameron JA, Pratt AG, Mellor AL, Isaacs JD, Scheel-Toellner D, Anderson AE

Publication type: Article

Publication status: Published

Journal: Immunology

Year: 2022

Pages: epub ahead of print

Online publication date: 25/10/2022

Acceptance date: 21/10/2022

Date deposited: 29/11/2022

ISSN (print): 0019-2805

ISSN (electronic): 1365-2567

Publisher: John Wiley and Sons Inc


DOI: 10.1111/imm.13598

PubMed id: 36281956


Altmetrics provided by Altmetric


Funder referenceFunder name
777357IMI Joint Undertaking
Innovative Medicines Initiative. Grant Number: 777357
JGW Patterson Foundation
NIHR Newcastle Biomedical Research Centre
Versus Arthritis. Grant Number: 22072